Latest news with #Marbio
Yahoo
11-06-2025
- Health
- Yahoo
Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
By Ahmed Eljechtimi RABAT (Reuters) -Global vaccine group Gavi is seeking new donors for its work funding childhood immunisation in the world's poorest countries, its chief executive told Reuters, as many traditional funders cut international aid budgets. Gavi is aiming to raise $9 billion at a summit in Brussels later this month for its work from 2026-2030, but countries including the United States, the United Kingdom and France have all signalled that they plan to slash global aid funding in the coming years, and their pledges remain uncertain. "We want to broaden our donor base," Gavi's Sania Nishtar told Reuters in Rabat, where she met officials to encourage Morocco to join as a new donor. She said that India and Indonesia, which had previously been supported by Gavi, were now contributing as donors to the organization, which works with low and middle-income countries to buy vaccines for diseases from measles to cholera. Other countries like Portugal have also increased their funding commitment, she said. During her Morocco visit, Nishtar toured a vaccine manufacturing facility near Casablanca under development by Marbio, a biopharmaceutical venture backed by Morocco. She said the plant had "a good chance" of benefiting from Gavi's $1.2 billion African Vaccine Manufacturing Accelerator, a scheme aimed at boosting vaccine production on the continent. Gavi has already sought out more private sector donors, initiated cost-saving initiatives, and discussed closer collaboration with other global health groups as part of plans to try to tackle potential shortfalls in funding. Nishtar said the organization was making contingency plans, but she hoped that donors at the June 25 summit would give enough that they would not be needed. A U.S. government document showed in March that the U.S., which has previously given around $300 million to Gavi annually, did not plan any future funding. Nishtar said that Gavi has not yet received this year's funding, which has already been approved by Congress. Gavi is currently focused on combating a global measles outbreak and is responding to cholera outbreaks in Sudan, South Sudan, and Angola, where it has made special arrangements to supply vaccines from its stockpiles, Nishtar said. It is also supporting Sierra Leone, where the spread of mpox has accelerated.
Straits Times
11-06-2025
- Health
- Straits Times
Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
RABAT - Global vaccine group Gavi is seeking new donors for its work funding childhood immunisation in the world's poorest countries, its chief executive told Reuters, as many traditional funders cut international aid budgets. Gavi is aiming to raise $9 billion at a summit in Brussels later this month for its work from 2026-2030, but countries including the United States, the United Kingdom and France have all signalled that they plan to slash global aid funding in the coming years, and their pledges remain uncertain. "We want to broaden our donor base," Gavi's Sania Nishtar told Reuters in Rabat, where she met officials to encourage Morocco to join as a new donor. She said that India and Indonesia, which had previously been supported by Gavi, were now contributing as donors to the organization, which works with low and middle-income countries to buy vaccines for diseases from measles to cholera. Other countries like Portugal have also increased their funding commitment, she said. During her Morocco visit, Nishtar toured a vaccine manufacturing facility near Casablanca under development by Marbio, a biopharmaceutical venture backed by Morocco. She said the plant had "a good chance" of benefiting from Gavi's $1.2 billion African Vaccine Manufacturing Accelerator, a scheme aimed at boosting vaccine production on the continent. Gavi has already sought out more private sector donors, initiated cost-saving initiatives, and discussed closer collaboration with other global health groups as part of plans to try to tackle potential shortfalls in funding. Nishtar said the organization was making contingency plans, but she hoped that donors at the June 25 summit would give enough that they would not be needed. A U.S. government document showed in March that the U.S., which has previously given around $300 million to Gavi annually, did not plan any future funding. Nishtar said that Gavi has not yet received this year's funding, which has already been approved by Congress. Gavi is currently focused on combating a global measles outbreak and is responding to cholera outbreaks in Sudan, South Sudan, and Angola, where it has made special arrangements to supply vaccines from its stockpiles, Nishtar said. It is also supporting Sierra Leone, where the spread of mpox has accelerated. REUTERS Join ST's Telegram channel and get the latest breaking news delivered to you.
Reuters
11-06-2025
- Health
- Reuters
Vaccine group Gavi seeks to broaden donor base as aid budgets shrink
RABAT, June 11 (Reuters) - Global vaccine group Gavi is seeking new donors for its work funding childhood immunisation in the world's poorest countries, its chief executive told Reuters, as many traditional funders cut international aid budgets. Gavi is aiming to raise $9 billion at a summit in Brussels later this month for its work from 2026-2030, but countries including the United States, the United Kingdom and France have all signalled that they plan to slash global aid funding in the coming years, and their pledges remain uncertain. "We want to broaden our donor base," Gavi's Sania Nishtar told Reuters in Rabat, where she met officials to encourage Morocco to join as a new donor. She said that India and Indonesia, which had previously been supported by Gavi, were now contributing as donors to the organization, which works with low and middle-income countries to buy vaccines for diseases from measles to cholera. Other countries like Portugal have also increased their funding commitment, she said. During her Morocco visit, Nishtar toured a vaccine manufacturing facility near Casablanca under development by Marbio, a biopharmaceutical venture backed by Morocco. She said the plant had "a good chance" of benefiting from Gavi's $1.2 billion African Vaccine Manufacturing Accelerator, a scheme aimed at boosting vaccine production on the continent. Gavi has already sought out more private sector donors, initiated cost-saving initiatives, and discussed closer collaboration with other global health groups as part of plans to try to tackle potential shortfalls in funding. Nishtar said the organization was making contingency plans, but she hoped that donors at the June 25 summit would give enough that they would not be needed. A U.S. government document showed in March that the U.S., which has previously given around $300 million to Gavi annually, did not plan any future funding. Nishtar said that Gavi has not yet received this year's funding, which has already been approved by Congress. Gavi is currently focused on combating a global measles outbreak and is responding to cholera outbreaks in Sudan, South Sudan, and Angola, where it has made special arrangements to supply vaccines from its stockpiles, Nishtar said. It is also supporting Sierra Leone, where the spread of mpox has accelerated.
Morocco World
21-05-2025
- Health
- Morocco World
WHO President Hails Transformation of Morocco's Health Sector
Rabat — Morocco's progress in the health sector has received commendation from Tedros Adhanom Ghebreyesus, the Director-General of the World Health Organization (WHO). The WHO chief expressed satisfaction with the Moroccan health sector's advances during a meeting with Morocco's Health Minister Amine Tehraoui in Geneva. The high-level talks took place on Wednesday as health leaders from around the world gathered for the 78th World Health Assembly, where a landmark pandemic agreement topped the agenda. During the pair's meeting, Tehraoui outlined Morocco's sweeping changes reshaping the North African country's healthcare sector under King Mohammed VI's leadership. Morocco's ambitious reforms aim to tackle long-standing challenges by ensuring fair access to care, achieving universal coverage, and dramatically improving healthcare quality nationwide. Tehraoui also revealed plans to transform Morocco into a regional powerhouse for medical manufacturing. At the heart of this strategy is the groundbreaking 'Marbio' initiative, which seeks to break Africa's dependence on imported medicines through technology transfer and local production capacity. Not only did the WHO chief commend Morocco's progress in the health sector, but he also pointed out its influential role on the WHO Executive Board, describing the country as a serious partner in global health security. Tedros pledged the WHO's continued support for Morocco's healthcare revolution, with the country undergoing what represents exactly the kind of transformation the world needs to see more of. As Morocco positions itself as a bridge between Europe, the Middle East, and the rest of Africa in addressing shared health challenges, this meeting signals the country's growing influence in regional health policy. Morocco has transformed its healthcare with modern infrastructure and international partnerships. Maternal mortality dropped 70% over two decades, reporting a decline from 244 to 72 deaths per 100,000 births between 2000 and 2020. The country plans to increase health professionals from 18 to 45 per 10,000 people by 2030 and boost health positions from 4,000 to 6,500 by 2025. The government is also developing a mental health strategy to serve the nearly half of Moroccans who may experience psychological disorders. Currently, 3,230 mental health professionals are mobilized to support these individuals. Tags: Health sectorMorocco health sectorWHO Morocco
